Zimmer looking at Sintx for spine and total joints?

[anonymous]

Catalyst Capital files $450-million lawsuit accusing Anson Funds, West Face of short-selling 'conspiracy'​

Lawsuit claims ‘Wolfpack Conspirators’ worked with group of borrowers who had defaulted on loans to Callidus



Catalyst Capital files $450-million lawsuit accusing Anson Funds, West Face of short-selling 'conspiracy'

And look at all the death spiraling penny stocks they crush. All with worthless CEO’s who have zero odors how to run a company…. Just like sintx

 

[anonymous]

Sonny Bal in Cahoots with Cliff Teller from Maxim. Sonny Bal been talking to Maxim for YEARS. Maxim knows everything about Sintx, and Sonny Bal has to know how he’s destroying shareholders by working with Maxim at this point. Only so many years can go by with the same results acting like you don’t know what’s going on. Complete BS. Sonny Bal in bed with Maxim. It was proven to Scott Mosier years ago, and he deleted it. Now it’s literally in Sintx SEC filings….

 

[anonymous]

Sonny Bal in Cahoots with Cliff Teller from Maxim. Sonny Bal been talking to Maxim for YEARS. Maxim knows everything about Sintx, and Sonny Bal has to know how he’s destroying shareholders by working with Maxim at this point. Only so many years can go by with the same results acting like you don’t know what’s going on. Complete BS. Sonny Bal in bed with Maxim. It was proven to Scott Mosier years ago, and he deleted it. Now it’s literally in Sintx SEC filings….

And years ago Scott Mosier claimed this was impossible, Sonny Bal would never talk to Maxim. Yet it was proven he did and it was deleted by Scott Mosier…. Everyone got to see it at least and make fun of Scott for that claim of Sonny Bal not taking to Maxim, that was probably 5 years ago… Now he’s asking us to prove it again….. Scott Mosier and Sonny Bal, at least the fraudsters stick together, like peas in a fraud pod.

 

[anonymous]

The following will show there has in fact been a conspiracy of funds, shorting and distorting SINT & Sintx for the past 9 years. My next post will give some insight into how this family of funds might operate. A third post will show that they target vulnerable but promising companies with valuable assets they can secure significant profits from, just how valuable Sintx IP could be, and methods used to defend Sintx from this conspiracy of funds.
Its worth noting that 3 of the family of funds appear to be accumulating a position, just like what was done to Nano in its lawsuit against this conspiracy of funds. Which means they could be getting ready to make their move. Look how it accumulated its position in Nano and then realize three of its family of hedge funds is currently accumulating positions: Anson Funds Management LP, L1 Capital Global Opportunities Master Fund, Ltd. , Lind Global Fund II LP .

https://i.imgur.com/gRnIWov.jpeg

Conspiracy of Funds

First off lets establish the conspiracy of funds working together. Fortunately, in another unrelated lawsuit, the list has been provided:

Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.

List of potential investors the Plaintiff was referencing. All the funds that seem to be connected are in red.

List named the following:
Anson Funds Management LP and its affiliates
Ayrton Capital, Altos Opportunity Fund and their
affiliates
Crede Capital Group, Acquitas Capital and its affiliates
CVI Investment, Heights Management, SIG and their
affiliates
Connective Capital and its affiliates
Empery Asset Management and its affiliates
Intracoastal Capital LP and its affiliates
Hudson Bay Capital Management and its affiliates
Ionic Venture LLC and its affiliates
Lind Partners and its affiliates
Li Capital Global Opportunities Master Fund and their
affiliates
Sabby Management LLC and its affiliates

https://images.law.com/contrib/cont.../51-2023-08-31-043-Order-Denying-SJMotion.pdf

History of those Funds stake in AMDA/SINT since 2015

List of Funds that have had stakes in AMDA/SINT at one time or another. The first three listed could be accumulating positions in SINT like what was done to NANO. These three funds are connected.

4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
EDGAR Filing Documents for 0001079973-24-000472

2024-05-14 13F Anson Funds Management LP 959,297 47
https://fintel.io/so/us/sint

2/07/24 Lind Global Fund II LP
EDGAR Filing Documents for 0000929638-24-000396

2/16/2023 INTRACOASTAL CAPITAL, LLC
EDGAR Filing Documents for 0001213900-23-012455

2/14/2023 Lind Global Fund II LP
EDGAR Filing Documents for 0000929638-23-000614

05/18/2018 CVI Investments, Inc.
EDGAR Filing Documents for 0001104659-18-034362

01/19/2017 SABBY MANAGEMENT, LLC
EDGAR Filing Documents for 0001535610-17-000068

07/14/2016 ALPHA CAPITAL ANSTALT
EDGAR Filing Documents for 0001213900-16-014963

9/14/2015 Frigate Ventures LP = Anson Group

This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Frigate Ventures LP (d/b/a Anson Group), a Texas limited partnership (“Frigate”), Admiralty Advisors LLC, a Texas limited liability company (“Admiralty”), Mr. Bruce R. Winson, the principal of Frigate and Admiralty, M5V Advisors Inc. (d/b/a Anson Group Canada), an Ontario, Canada corporation (“M5V”), Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V, relating to Common Stock, $.01 par value (the “Common Stock”), of Amedica Corporation, a Delaware corporation (the “Issuer”).

EDGAR Filing Documents for 0001193125-15-319457

Hudson Bay Capital Management LP 2,789,867 2.16 870,438 Sep 30, 2015
SiNtx Technologies Inc (SINT): AMDA Institutional Holders(as of 9/30/15...


XenaLives connecting CVI to ALPHA CAPITAL ANSTALT
SiNtx Technologies Inc (SINT): There will be footprints - ALPHA CAPITA...


Lawsuit Sources:
EX-99.3
https://images.law.com/contrib/cont.../51-2023-08-31-043-Order-Denying-SJMotion.pdf

This case connects additional funds to Anson that have not had a stake in SINT in the past like Empery Asset Management.
https://casetext.com/case/augenbaum-v-anson-invs-master-fund-8

 

[anonymous]

Scott Mosier. The r*****. Sonny Bal in bed with the worst of the worst. In cahoots with criminals, and should be in jail with yourself you fraudulent scammers. Sintx = Scam. Why you think the sharks smell blood in the water, Sonny Bal been bleeding Sintx out since 2014. Sharks aren’t dumb, and Sonny isn’t smart. People have to be Stupid not to short this penny stock, it’s what’s done to companies who don’t know what they are doing. As you have posted, if you’re involved with any of the above you f’d up big time, and you showed your cards and will be taken advantage of like Sonny Bal has his entire existence at sintx. Dumb doesn’t cut it when sharks are biting. Sonny Bal has to be involved at this point. Scott, report the sharks to the SEC as we all have been doing for years! Welcome to the club you moron.

 

[anonymous]

This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.

Here is a trade that is almost guaranteed to make money, though it is also double super illegal.

These companies -- there were 13 of them, all pretty small -- raised money through what the SEC calls "confidentially marketed public offerings." A company would engage an investment bank, which would call up potential investors and ask if they wanted to buy shares in the company. The bank would do this before the company publicly announced the offering, and would "wall-cross" the potential investors, making them agree to keep the information about the offering secret until it was announced publicly.

So here's a predictable stock-market pattern and an easy way to exploit it: If a company calls you up to ask you to invest in its upcoming public offering, you should (1) say yes, (2) sell the company's stock short before the public announcement, and then (3) buy the stock back in the public offering, generally at a 10+ percent discount, a few days later.

This is of course not legal advice! It is a great trade, but it is also double super illegal, insofar as:

There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering, 5 and
There is a general, and much more important, rule against trading on purloined material nonpublic information, and this is that.

trading in breach of that agreement, you are clearly violating not just the contract, but also insider trading laws, which make it illegal to trade "in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security."

But, you know, who will check?

Some of the funds would get wall-crossed, and then they'd tip each other and trade in the other funds to try to obscure what was going on:

When they were successful in obtaining such information, Fishoff shorted the issuer’s stock in advance of the offerings, directed trading by Chernin and Costantin in those instances when he did not place the trades on his own, and tipped Petrello, who then also shorted the stock through Brielle and Oceanview.

In many instances, the Fishoff-controlled entities for which Chernin and Costantin were fronting also participated in the offering, with the stock going to Featherwood’s account and often being used to cover the short sales.

This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?

By cheating on their wall-cross agreements and shorting the stock, these guys had the effect of driving down the stock price, which probably reduced the price in the offering. These companies probably got less money for their stock because their nonpublic information was (allegedly) used against them.

Though you could have a more cynical view of this sort of thing. A company needs to sell stock, but worries that announcing a public offering will drive down its stock price and not produce any takers. So it calls some investors up privately and tells them it's doing a deal. Those investors agree to invest in the deal, but before the deal is announced they lay off their risk by shorting the company's stock. Then the deal is announced and the investors buy shares from the company to (illegally) cover their shorts. The investors get their 10 percent, or whatever, discount to the market price as a commission; their real function is not to invest in the deal but to intermediate between the company (which can't sell stock without a publicly disclosed offering) and the unsuspecting public (which buys from the "investors" before the public disclosure). The wall-cross agreement creates deniability for the company. No one's stealing from the company; they're helping the company get a deal done that would otherwise be much harder to achieve. The victims are the public who buy from the insider traders at the inflated, pre-announcement price.

There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering, these funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).

You short 16 million, knowing once the offering price is announced, the stock will take a hit. Voila, in 24 to 48 hours you just made 1.6 million by buying back at .15 +

Fund A would be the one that bought the offering, in this case Lind Group. Funds B, etc.. (theres like 9 funds identified so far) would be the ones naked shorting like described here by Joev2. For which i replied:

Its the hfunds that made the $1.6m you describe. Also they NAKED shorted on news of the R&D contract with the army, thus they NAKED shorted from .25-.50 range making alot more than the $1.6m you mentioned. If every .1 represents $1.6m profit then if they have an average Naked short position of .35 then that translates to $3.2m in 24 to 48 hours. Essentially funding the offering in 1-2 day period.

They announced the news on Jan 30th when these funds pre-naked shorted the offering and the offering closed on Feb 2nd. This is exactly the scenario depicted in the above and its accomplished by trading inside information and using multiple hedge funds to bypass the sec rule that prevents funds from shorting before an offering they participate in. Then these funds can wash trade the stock price lower trading back and forth between each other, to make even more money shorting the stock. You can see how many naked shares that remained uncovered by the 2nd of Feb.

20240202|829392604|SINT|5,939,951|SINTX TECHNOLOGIES INC COM COM|0.15

Something posted by XenaLives years ago and it seems to correlate with all this, especially post split as theyve been walking the price down.

The 10000 can be wash traded back and forth freely between colluding computers. Tons of money is made so they can now walk the stock down even lower because risk has been reduced.

Instead of thinking of this as simply colluding computers, think of it as Fund A & Fund B colluding to trade back n forth to walk the price down. Anson and the other funds in the family are well known for this sort of behavior and they couldnt have been more obvious about it after the Feb 2023 offering.

Quote Sources:
Insider Traders Made Some Easy Money on Stock Offerings
SiNtx Technologies Inc (SINT): I'm not sure either of us know enoug...
Replies to Post #40496 onSiNtx Technologies Inc (SINT) | InvestorsHub
SiNtx Technologies Inc (SINT): Yes, but it's an extremely low float...

 

[anonymous]

Sintx is out of money again, selling shares for what the 4th time this year to raise money to keep the lights on and paychecks coming? Diluting shareholders again and again, Bal should be in prison. Scott Mosier is the type of person to let Epstein babysit his kids even though everyone else in the world knows what happens on that island. Scott sees the best in people, always, even when the kids are crying he still refuses to see what’s going on with sintx. No joke here, guy is mentally unstable.

 

[anonymous]

According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. IP thats destined to take over the ortho industry according to one study linked at the bottom of this post.

Their playbook is simple: they find a promising company like Nano that has attracted significant investment, furtively acquire a large position, and then seek to dismantle the company and distribute its cash for Defendants’ own benefit.

EX-99.3

So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed. A work in progress.

Transitive Property:

In 2003, Zimmer acquired a materials company for $232m with $108m of it upfront and the remaining $124m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabecular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee. That said, Trabecular metal cannot be used as a coating or imbued in materials like silicon nitride can to bring those materials its beneficial enhancements. Thus its market potential in the ortho/dental markets was smaller.

Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m

Accumulated Deficit and Tax Write-off

Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Also, acquiring Sintx for that amount would increase goodwill which is an asset the acquiring company can depreciate and thus provide additional tax benefit as well as increase its assets.

Potential Market Size

One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.

Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.

Markets Si3n4 can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn

Total = $324.36bn

Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal. A new patent was awarded Sintx for the use of Si3n4 against funguses that impact the wine industry providing yet another market it can tap into. This could be a market that they could break into sooner than some of the others listed above but it wouldnt be as lucrative.

In Summary, you can see that Sintx has extremely valuable IP that can be used in markets that are cumulatively in the hundreds of billions in size. That is why Anson and the other family of funds its connected to would want to get their hands onto that IP. Like Nano, it looks like this conspiracy of funds was getting ready to make a move before I exposed them with three of the funds accumulating a position this year. However recent offerings by management seems to have helped in diluting their positions to prevent a similar situation to Nano as shown in the first of these three posts.
Because Sonny has employed several methods of protection to protect Sintx IP from hostile entities, their only option to get the IP is hope they can drive Sintx into bankruptcy as Sonny has setup crown jewels defense in the event this group attempts a hostile takeover. As Sintx has no debt, Sonny and then board cannot be forced into selling the IP to a particular entity. Upside to Sintx not having loans and likely a big reason it has not obtained one so since Hercules loan in 2014.

4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
EDGAR Filing Documents for 0001079973-24-000472

Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.

(2) Based on 51,080,139 shares of Common Stock outstanding as reported in the Issuer’s filings with the Securities and Exchange Commission.

Once this offering completed, L1 stake in Sintx became 3.6%.

This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position (Poison Pill type offering?). Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds as well as raising needed funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. This has likely prompted the recent new of Sintx exploring strategic opportunities.


Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market

=======================================

Here are all the anti-takeover provisions employed at Sintx.

1. Poison pill aka Shareholder Rights Plan

2. Staggered Board

3. Shark Repellant - requiring supermajority vote

4. Golden Parachute for management

5. Crown Jewel Defense - CTL has first rights to acquire Sintx IP.

6. CTL is setup as a White Knight via its first rights to acquire Sintx IP.

7. If Sintx sold its main IP to CTL thats effectively scorched earth as Sintx has little value, in comparison, without its patent portfolio. Sintx would still have TA&T & Sintx Armor for value in the event it had to sell its core Si3n4 IP to CTL, even if for a short time.

========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

 

[anonymous]

Sintx is out of money again, selling shares for what the 4th time this year to raise money to keep the lights on and paychecks coming? Diluting shareholders again and again, Bal should be in prison. Scott Mosier is the type of person to let Epstein babysit his kids even though everyone else in the world knows what happens on that island. Scott sees the best in people, always, even when the kids are crying he still refuses to see what’s going on with sintx. No joke here, guy is mentally unstable.

You ever notice whenever Scott Mosier pumps sintx in Zimmer forums that Sintx is about to or in the middle of diluting shareholders via offerings and or reverse splits. Goes on the hardcore offense trying to cover up any and all warnings about Sonny Bal and the Amedica aka Sintx disaster of a company. Sintx literally in middle of screwing shareholders and he’s praising them 24/7 trying to blame everyone but the company. If you see Scott Mosier pumping Sintx, look out, they about to take your investment. It’s been PROVEN now for years, see and hear sintx pumpers you know they are desperate.

 

[anonymous]

You ever notice whenever Scott Mosier pumps sintx in Zimmer forums that Sintx is about to or in the middle of diluting shareholders via offerings and or reverse splits. Goes on the hardcore offense trying to cover up any and all warnings about Sonny Bal and the Amedica aka Sintx disaster of a company. Sintx literally in middle of screwing shareholders and he’s praising them 24/7 trying to blame everyone but the company. If you see Scott Mosier pumping Sintx, look out, they about to take your investment. It’s been PROVEN now for years, see and hear sintx pumpers you know they are desperate.

18 Rules of Disinformation​

Sidetrack opponents with name calling and ridicule.​

A form of an ad hominem attack, define the opponent with a label rather than inferior argumentation.

Proper response: Explain that such an approach implies “guilt by association and attack truth on the basis of the messenger” (Sweeney).

SEC Charges Canadian Investment Adviser with Violating Trading Rule

The SEC's order finds that AAI violated Rule 105 of Regulation M under the Securities Exchange Act of 1934 ("Rule 105"), which prohibits short selling an equity security during a restricted period (generally five business days before a covered public offering) and then purchasing the same security in the offering, absent an exception. The rule applies regardless of the trader's intent and is designed to prevent potentially manipulative short selling before the pricing of covered offerings. The SEC's order finds that AAI violated Rule 105 by participating in three follow-on offerings occurring in December 2019, June 2020, and April 2021, respectively, after it had engaged in short sales of the same securities during the restricted period, and that AAI's violations stemmed from an incorrect understanding of how to comply with an exception to Rule 105.

This is precisely what this family of funds did during the Feb 2023 and Jan 2024 offerings. This consortium of funds also seemed to have violated the following assuming they collectively owned more than 10% of the stock.

Short-swing trading is defined as the purchase and sale (or vice versa) of a company’s stock within a six-month period by persons deemed to be ‘insiders,’ who are presumed to have access to confidential corporate information not generally available to other participants in the public mar-ket.” Morales v. Quintel Ent., Inc., 249 F.3d 115, 121 (2d Cir. 2001). An insider is “a person who is directly or indirectly the beneficial owner of more than 10 percent of any class of any equity security.” 15 U.S.C. § 78p(a)(1). The SEC’s regulations do not require that a single person own more than 10%. Instead, a “per-son” will be“deemed a beneficial owner pursuant to section 13(d) of the [Exchange] Act and the rules thereunder.” 17 C.F.R. § 240.16a-1(a)(1); Morales, 249 F.3d at 122. And § 13(d) states that a beneficial owner can be a “group.” 15 U.S.C. § 78m(d)(3) (“When two or more persons act as a . . . group for the purpose of acquiring, holding, or disposing of securities of an issuer, such . . . group shall be deemed a ‘person’ for the purposes of this subsection.”). Consistent with § 13(d), Rule 13d-5(b) states that a group is formed when “two or more persons agree to act together for the purpose of acquiring, holding, voting or disposing of equity securities of an issuer.” 17 C.F.R. § 240.13d-5(b)(1); see alsoRoth v. Jennings, 489 F.3d 499, 507–08 (2d Cir. 2007). That agreement “may be formal or informal and may be proved by direct or circum-stantial evidence.” Morales, 249 F.3d at 124. Finally, to be held liable under § 16(b), a trader must be an insider at the time of both purchase and sale. 15 U.S.C. § 78p(b). And both trades must take place within a six-month window. Id

Quote Sources:

https://www.sec.gov/enforcement-litigation/administrative-proceedings/34-98775-s
https://law.justia.com/cases/federal/district-courts/new-york/nysdce/1:2022cv00249/573076/142/

 

[anonymous]

You ever notice whenever Scott Mosier pumps sintx in Zimmer forums that Sintx is about to or in the middle of diluting shareholders via offerings and or reverse splits. Goes on the hardcore offense trying to cover up any and all warnings about Sonny Bal and the Amedica aka Sintx disaster of a company. Sintx literally in middle of screwing shareholders and he’s praising them 24/7 trying to blame everyone but the company. If you see Scott Mosier pumping Sintx, look out, they about to take your investment. It’s been PROVEN now for years, see and hear sintx pumpers you know they are desperate.

This is 100 percent the truth. Scott Mosier a paid pumper for sintx. only here when sintx needs money and gets more suckers to give it to them. cry harder Scott, they called me names, waaaaaa. You are a fraud, everyone knows it, even yourself.

 

[anonymous]

This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position (Poison Pill type offering?). Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds as well as raising needed funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. This has likely prompted the recent new of Sintx exploring strategic opportunities.

The new offering, whenever it will happen, will effectively double the OS at current levels, diluting these funds positions again, assuming they are re-accumulating. This could be what continues to happen. Frequent small offerings to dilute this conspiracy of funds and continue to raise funds at the same time. I've exposed more of the funds connected to this conspiracy so hopefully that'll help monitor them collectively accumulating positions without triggering disclosure. I believe we can expect more of these small offerings on about a quarterly basis because Sonny needs to keep the price over $1 while diluting these hostile funds positions.

 

[anonymous]

Hey light bright. The SEC has exposed all these crooks and guess what. Sintx CEO Sonny Bal still works with them hand in hand. Takes one crook to know another. Sonny ball has zero idea what he is doing expect knowingly screwing his shareholders over year after year after year after year. No other reason he would still work with these companies. Criminal behavior 100%.

 

[anonymous]

Here are all the anti-takeover provisions employed at Sintx.

1. Poison pill aka Shareholder Rights Plan

2. Staggered Board

3. Shark Repellant - requiring supermajority vote

4. Golden Parachute for management

5. Crown Jewel Defense - CTL has first rights to acquire Sintx IP.

6. CTL is setup as a White Knight via its first rights to acquire Sintx IP.

7. If Sintx sold its main IP to CTL thats effectively scorched earth as Sintx has little value, in comparison, without its patent portfolio. Sintx would still have TA&T & Sintx Armor for value in the event it had to sell its core Si3n4 IP to CTL, even if for a short time.

The increase in the number of shares of authorized but unissued and unreserved Common Stock will have an “anti-takeover effect”by permitting the issuance of shares to purchasers who might oppose a hostile takeover bid or oppose any efforts to amend or repeal certain provisions of our Charter. The increased number of available authorized but unissued shares of Common Stock as a result of the Reverse Split would give the Company’s management more flexibility to resist or impede a third-party takeover bid that provides an above-market premium that is favored by a majority of the independent stockholders.

Something not included in regards to previous reverse splits. As you can see part of the reason for the reverse split was so they could issue shares to purchasers who might oppose a hostile takeover even at above market premium. Well that premium would have to be significant to be worth consideration by stockholders when you look at the size of the potential markets Sintx IP can be used in.

https://www.sec.gov/Archives/edgar/data/1269026/000149315224014753/formdefn14a.htm pg 9

 

[anonymous]

Sintx. The scam that never stops. CEO works with companies to screw shareholders over non stop. So many SEC violations and fines from the companies he chooses to work with that clearly destroy companies and stocks. Sonny Bal has been working with these companies for years and years, even after the SEC takes these companies to court for the games the play with stocks. Sonny Bal and Sintx 100% involved in destroying shareholders for paychecks. Zero fiduciary duty, no shareholder meetings, no questions allowed. Sintx is a pure nightmare. That’s why they need pumpers like Scott Mosier to try and sell the diluted shares for them as everyone, including Sonny Bals knows what happens to these offerings. Sad sad world when the company knows they are being screwed and actively works with the companies screwing them. It’s no wonder why nobody at sintx buys shares in sintx, they all know it’s bs. Sintx is exactly what happens when everyone but shareholders make money, dirty dirty dirty. All of them.

 

[anonymous]

Scott Mosier is deleting comments again, this guy is the biggest loser ever. Refuses to debate on anything, just deletes real people with real concerns that we all share about sintx, except Scott Mosier and Sonny bal. 2 criminals who just can’t let others talk, especially if it’s about their performance over 10 year time span at this point. Both have nothing positive to show, both use and abuse people, both should be locked up, doing time.

 

[anonymous]

Here we go again, Sintx pumpers using Zimmer to pump sintx while they actively dilute shareholders for the bazillionth time. SiNtx Technologies Inc (SINT): No everyone does not know that TA. Other...

Per Scott Mosier Zimmer spent 20 years now trying to make a hip implant. Everyone asks Sintx what happened to that 2nd hip study that was supposed to come out YEARS ago per Sintx?? Why doesn’t Scott Mosier EVER ask sintx where that study is?? Huh Scott? Why?

 

[anonymous]

One of the co-founders (Dr. Hofmann, MD) of Sintx was a surgeon designer for Centerpulse. Obviously his contracts transferred to Zimmer beginning in 2003 after the acquisition.
Dr Link, PHD who was CEO of Centerpulse upon acquisition became Chairman of Sintx the same month Zimmer - Centerpulse deal closed (Oct 2003).
2005 - Dr Sonny Bal who was on Zimmer's Surgeon Panel from 2002- ?, joined Sintx as a surgeon designer before joining the board in 2012, becoming Chairman (Aug 2014), and CEO Oct 2014 - 2024. Dr Bal is now only Chairman.
2007-

2007 (ORS Annual Meeting Feb 11-14)

THERMAL CONDUCTIVITY OF FEMORAL BALL STRONGLY INFLUENCED UHMWPE WEAR IN A HIP SIMULATOR STUDY
Ten 28 mm ID isostatically moulded UHMWPE liners were investigated: GUR 1050 resin, gamma-sterilized with 25ñ40 kGy in argon (ArComô, Biomet Inc, Warsaw, IN). The liners were coupled with zirconia (Y-ZrO 2 : ProzyrÆ), cobalt-chrome (Biomet, Inc), silicon nitride (Si3 N 4 : Amedica-Inc, UT) and alumina femoral balls (Al2 O 3 : Biolox-forteÆ) (Figure 1).
Acknowledgements The authors thank Amedica, Utah, US and Biomet Inc, US for their support

The fact that the results were presented Feb 2007 means that the study took place in 2006 or earlier. Maybe thats why Dr Bal joined Sintx then? Shared resouce to aid in the development of a co-developed hip implant?

I could go on and on. However i do not think Zimmer Biomet is going to acquire Sintx tech yet. A more immediate concern is NP Aerospace who i talk about over on ihub. Watch for some sort of development to occur between these two companies as Sintx can still produce armor out of its Maryland facility.
Quick background on NP Aerospace is the company was divested from Morgan Ceramics a company that was partnered with Sintx from 2016 - ? and who i believe Sintx is now suppling aerospace components for as thats one of the things being co-developed back then. However the name of the company in the 10 year aerospace agreement was not disclosed.
NP Aerospace was Morgans armor division before, in 2018, it was divested. Interestingly Sintx closed its deal with CTL Oct 2018 when it became Sintx and NP deal closed Nov 2018.

Dr. Bal's 2014 resume showing he was part of Zimmer's Surgeon Panel:
https://web.archive.org/web/2024031...com/wp-content/uploads/2014/04/Dr.-Bal-CV.pdf

Amedica + Biomet Study in 2007 source:
http://c.eqcdn.com/_5c7526ae538a6086a4025ef13f5136d2/amedica/db/265/660/pdf/0278.pdf

========================================

Section 2 - A conspiracy of shorting and distorting.

This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
SiNtx Technologies Inc (SINT): The following will show there has in fac...

This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
SiNtx Technologies Inc (SINT): This is essentially how the Anson family...

According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
SiNtx Technologies Inc (SINT): According to this lawsuit, Anson and its...

 

[anonymous]

One of the co-founders (Dr. Hofmann, MD) of Sintx was a surgeon designer for Centerpulse. Obviously his contracts transferred to Zimmer beginning in 2003 after the acquisition.
Dr Link, PHD who was CEO of Centerpulse upon acquisition became Chairman of Sintx the same month Zimmer - Centerpulse deal closed (Oct 2003).
2005 - Dr Sonny Bal who was on Zimmer's Surgeon Panel from 2002- ?, joined Sintx as a surgeon designer before joining the board in 2012, becoming Chairman (Aug 2014), and CEO Oct 2014 - 2024. Dr Bal is now only Chairman.
2007-


The fact that the results were presented Feb 2007 means that the study took place in 2006 or earlier. Maybe thats why Dr Bal joined Sintx then? Shared resouce to aid in the development of a co-developed hip implant?

I could go on and on. However i do not think Zimmer Biomet is going to acquire Sintx tech yet. A more immediate concern is NP Aerospace who i talk about over on ihub. Watch for some sort of development to occur between these two companies as Sintx can still produce armor out of its Maryland facility.
Quick background on NP Aerospace is the company was divested from Morgan Ceramics a company that was partnered with Sintx from 2016 - ? and who i believe Sintx is now suppling aerospace components for as thats one of the things being co-developed back then. However the name of the company in the 10 year aerospace agreement was not disclosed.
NP Aerospace was Morgans armor division before, in 2018, it was divested. Interestingly Sintx closed its deal with CTL Oct 2018 when it became Sintx and NP deal closed Nov 2018.

Dr. Bal's 2014 resume showing he was part of Zimmer's Surgeon Panel:
https://web.archive.org/web/2024031...com/wp-content/uploads/2014/04/Dr.-Bal-CV.pdf

Amedica + Biomet Study in 2007 source:
http://c.eqcdn.com/_5c7526ae538a6086a4025ef13f5136d2/amedica/db/265/660/pdf/0278.pdf

========================================

Section 2 - A conspiracy of shorting and distorting.

This posts shows that there is a family of funds connected to the Anson Group and how those funds took turns participating in Sintx stock offerings over the years.
SiNtx Technologies Inc (SINT): The following will show there has in fac...

This post shows how this group of funds work together to short offerings and buy them so to circumvent rule 17 CFR § 242.105a - Short selling in connection with a public offering. That said, they do appear to be violating the rules on trading material non-public information.
SiNtx Technologies Inc (SINT): This is essentially how the Anson family...

According to this lawsuit, Anson and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. The following post goes into how much the company should be valued, methods used to protect IP, and sheer product addressable market size of over $320 billion.
SiNtx Technologies Inc (SINT): According to this lawsuit, Anson and its...

Deflect much? Why does Scott Mosier not ask Sintx questions? Why does he feel he represents them? Where is that 2nd femoral head study? What happened to the life long joint program? Why wasn’t sintx invited until the VERY end of the program? What’s the difference in Si3n4 that failed for life long joints? No second femoral head study released as sintx said was coming, then results of life long joint program came, sintx scrambled to try and use theirs as results were not satisfactory, only for program to be finished all together, with no Si3n4 joints. Why Scott? Why aren’t you asking these questions? Just deflect and try and cover up with long nonsense. The world knows Scott Mosier is a fraud, the world also knows Sintx ran by Sonny Bal ripped off investors for 10 years with lies and false hope. Scott Mosier will look like a fool for life for sticking up for fraudsters like himself, I guess it takes one to know one. Keep deflecting Scott. Makes you and sintx look even more desperate. The black cloud that follows you and your family is well deserved at that point.

 

[anonymous]

Not deflecting. You said i was claiming Zimmer spent 20 years trying to make a hip implant with Sintx. I was showing evidence of just that which included sending Dr Bal to Sintx. I was also clarifying that i do not think Zimmer is ready to step up with Sintx and a more pressing concern in NP Aerospace as Sintx explores strategic opportunities.

As to the LifeLongJoints program, they used a method of coating metals that was not effective enough. If i recall correctly, the coatings flaked off for lack of a better description. However Sintx has long moved past that method of coating metals. Just to clarify something, the LLJ program did not use Sintx femoral heads. The program was designed to test methods of coating metal femoral heads and other hip components.

As to where Sintx second femoral head study is, I do not know? I can only go off recent material as to the status of its hip development beginning with this from their recent press release about exploring Strategic Opportunities:

More recently, the Company’s femoral head technology has attracted renewed interest from several global partners.

That suggests that there is still interest in their femoral head which would include Zimmer Biomet.

The LifeLongJoints program ended in 2018. It was designed to be a 5 year program so it ended when it was supposed to. There are two scientific studies i often reference that came out in 2021 and 2023 that have no connection to Sintx.

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies

This more recent study, while not realizing Amedica and Sintx are the same company, indicates that Silicon Nitride is one of the next generations of material to be used in hip implants and that Silicon Nitride is the closest to commercialization. This was the study released in 2023.


This study released in 2021 goes into more detail about the failures of the LLJ program coating technique and challenges of new coating techniques.

Since the deposition of silicon nitride coatings on metallic substrates requires the addition of binder metal oxides such as Al2O3 + Y2O3, no phase-pure homogeneous silicon nitride coatings could be produced to date. This problem was, at least partially, solved by spraying particles with high velocities up to 3 km/s that were generated by an electromagnetically accelerated plasma (EMAP). Under these extreme conditions, dense, homogeneous silicon nitride coatings with reduced amounts of binder oxides could be deposited with suitable mechanical properties, including tight adhesion to the surface of polished stainless steel [13,14].
Figure 3 shows that such dense and well-adhering, mechanically stable silicon nitride-based coatings on austenitic stainless-steel substrates deposited by conventionally detonation spraying (left) and ultrahigh-velocity pulsed plasma spraying, EMAPS (right). However, at the time of the writing, the novel technology has not progressed to a state where the pulsed mode could be replaced by a continuous delivery mode. Consequently, the deposition process is still economically untenable while tedious, since after each ‘shot’, the detonation chamber must be refilled with powder to be ready for the next shot. Nevertheless, this advanced deposition method may be at the cutting edge of future medical coating technologies designed for silicon nitride coatings as a protective bearing surface for novel arthroplastic devices or ceramic hip resurfacing (HR) prostheses (see below).

As you can see this method developed while being cutting edge for the future, is too expensive and tedious to use for now. Thus 3d printing is being utilized:

Recently, additive manufacturing techniques such as robocasting have been enlisted for producing silicon nitride scaffolds with controlled porosity and suitable mechanical properties. Details can be found in Section 4.3 below.

Sintx has several partnerships in relation to 3D printing. Companies like 3DCeramSinto and Prodways with its 3D printing. It also acquired TA&T for its 3D printing technology and resins. This is also why it was working with Morgan Ceramics in the first place, to help it develop techniques for coating metal components with Silicon Nitride. Morgan wanted to use the techniques for Aerospace applications and Sintx for medical.

Quote Sources:

SINTX Technologies to Explore Strategic Opportunities
Updates on Biomaterials Used in Total Hip Arthroplasty (THA)
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application